You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康希諾生物-B(06185.HK)2019年實現收入228.3萬元
格隆匯 03-19 19:22

格隆匯3月19日丨康希諾生物-B(06185.HK)公告,有關公司就申請首次公開發售A股及上市的第一輪問詢函的答覆文件刊載於上交所科創板股票發行上市審核網站(kcb.sse.com.cn)。

公司及其附屬公司截至2019年12月31日止年度的未經審計合併財務報表概要載於第一輪答覆。未經審計合併財務報表乃根據中國企業會計準則編制,並經由普華永道中天會計師事務所(特殊普通合夥)按照《中國註冊會計師審閲準則第2101號-財務報表審閲》的規定執行了審閲。

截至2019年12月31日止年度,公司營業收入228.3萬元,淨虧損1.57億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account